@ARTICLE{
author={Oh Jiwon|,Drulovic Jelena S|0000-0002-4516-3458,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Cheng Ying-Fang|,Harp Christopher|,Sierzega Malgorzata|,Clayton David|,Ratchford John|,Goodyear Alexandra|,Bar-Or Amit|},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit|,Oh Jiwon|,Dufek Michal|,Budincevic Hrvoje|,Habek Mario|,Caunt Maresa|,Thomas Piia|,Sierzega Malgorzata|,Clayton David|,Cheng Ying Fang|,Ratchford John|,Goodyear Alexandra|,Drulovic Jelena S|0000-0002-4516-3458},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hua Le|,Bar-Or Amit|,Weber Martin|,Habek Mario|,Budincevic Hrvoje|,Thomas Piia|,Napieralski Julie|,Ratchford John|,Qi Qi|,Sierzega M|,Drulovic Jelena S|0000-0002-4516-3458},
year={2023},
title={Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={-},
document_type={Meeting Abstract},
}